Selective modulation of inducible nitric oxide synthase isozyme in myocardial infarction

被引:72
作者
Wildhirt, SM [1 ]
Suzuki, H [1 ]
Horstman, D [1 ]
Weismuller, S [1 ]
Dudek, RR [1 ]
Akiyama, K [1 ]
Reichart, B [1 ]
机构
[1] HUNTINGTON MED RES INST, DEPT EXPT CARDIOL, PASADENA, CA USA
关键词
myocardial infarction; regional blood flow; hemodynamics; ischemia;
D O I
10.1161/01.CIR.96.5.1616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Inducible nitric oxide synthase (iNOS) is activated in cardiac disorders, We investigated the contribution of increased iNOS activity to the development of left ventricular dysfunction after myocardial infarction by selective inhibition of the isozyme. Methods and Results Male New Zealand rabbits were subjected to myocardial infarction, Animals were treated with either saline, S-methylisothiourea sulfate (SMT) (a selective iNOS inhibitor), or N-omega-nitro-L-arginine (L-NNA) (a nonselective NOS inhibitor). Inducible and constitutive NOS (cNOS) activity, plasma NOx, cGMP, hemodynamics, and myocardial blood flow were measured before and 5: 24, and 72 hours after coronary occlusion. Infarction 72 hours after occlusion resulted In increased myocardial iNOS activity, increased cardiac NOx production, and elevated cGMP levels. cNOS remained unchanged. Infarction increased left ventricular end-diastolic pressure (LVEDP) and decreased maximum +dP/dt and -dP/dt. L-NNA inhibited iNOS and cNOS activities and plasma NOx levels. L-NNA further increased LVEDP and reduced myocardial blood flow. Administration of SMT 72, hours after infarction significantly inhibited iNOS and cardiac NOx production but had no effects on cNOS. SMT improved left ventricular maximum +dP/dt and -dP/dt and decreased LVEDP. Myocardial blood flow in the remote myocardium increased. Conclusions These findings suggest that induction of iNOS activity 72 hours after infarction exerts negative inotropic effects and contributes to the development of myocardial dysfunction! selective modulation of increased iNOS activity by SMT improves cardiac performance, enhances myocardial blood flow, and may be beneficial in the treatment of acute myocardial infarction.
引用
收藏
页码:1616 / 1623
页数:8
相关论文
共 38 条
[31]   IN-VIVO PHARMACOLOGICAL EVALUATION OF 2 NOVEL TYPE-II (INDUCIBLE) NITRIC-OXIDE SYNTHASE INHIBITORS [J].
TRACEY, WR ;
NAKANE, M ;
BASHA, F ;
CARTER, G .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1995, 73 (05) :665-669
[32]   ACUTE AND CHRONIC INHIBITION OF NITRIC-OXIDE SYNTHASE IN CONSCIOUS RABBITS - ROLE OF NITRIC-OXIDE IN THE CONTROL OF VASCULAR TONE [J].
WARD, JE ;
ANGUS, JA .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 21 (05) :804-814
[33]   IMMUNOHISTOCHEMISTRY IN THE IDENTIFICATION OF NITRIC-OXIDE SYNTHASE ISOENZYMES IN MYOCARDIAL-INFARCTION [J].
WILDHIRT, SM ;
DUDEK, RR ;
SUZUKI, H ;
PINTO, V ;
NARAYAN, KS ;
BING, RJ .
CARDIOVASCULAR RESEARCH, 1995, 29 (04) :526-531
[34]  
Wildhirt SM., 1995, ENDOTHELIUM, V3, P209, DOI 10.3109/10623329509024667
[35]   MODULATION OF IN-VIVO ALLOREACTIVITY BY INHIBITION OF INDUCIBLE NITRIC-OXIDE SYNTHASE [J].
WORRALL, NK ;
LAZENBY, WD ;
MISKO, TP ;
LIN, TS ;
RODI, CP ;
MANNING, PT ;
TILTON, RG ;
WILLIAMSON, JR ;
FERGUSON, TB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :63-70
[36]   PROTECTIVE AND PATHOLOGICAL ROLES OF NITRIC-OXIDE IN ENDOTOXIN-SHOCK [J].
WRIGHT, CE ;
REES, DD ;
MONCADA, S .
CARDIOVASCULAR RESEARCH, 1992, 26 (01) :48-57
[37]   INDUCTION OF MYOCARDIAL NITRIC-OXIDE SYNTHASE BY CARDIAC ALLOGRAFT-REJECTION [J].
YANG, XC ;
CHOWDHURY, N ;
CAI, BL ;
BRETT, J ;
MARBOE, C ;
SCIACCA, RR ;
MICHLER, RE ;
CANNON, PJ .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (02) :714-721
[38]   INHIBITION OF SYMPATHETIC VASOCONSTRICTION IS A MAJOR PRINCIPLE OF VASODILATION BY NITRIC-OXIDE IN-VIVO [J].
ZANZINGER, J ;
CZACHURSKI, J ;
SELLER, H .
CIRCULATION RESEARCH, 1994, 75 (06) :1073-1077